应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NAGE Niagen Bioscience
交易中 12-16 12:28:10 EST
6.32
-0.05
-0.86%
最高
6.43
最低
6.24
成交量
25.46万
今开
6.34
昨收
6.37
日振幅
3.06%
总市值
5.05亿
流通市值
3.25亿
总股本
7,992万
成交额
160.82万
换手率
0.50%
流通股本
5,141万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Niagen Bioscience宣布1000万美元股票回购计划
投资观察 · 11-20
Niagen Bioscience宣布1000万美元股票回购计划
Niagen Bioscience Inc:全年重申其最近修订的净销售额增长指引为同比增长25%至30%
美股速递 · 11-05
Niagen Bioscience Inc:全年重申其最近修订的净销售额增长指引为同比增长25%至30%
异动解读 | Niagen Bioscience盘前大涨20.53%,季度业绩大幅超预期
异动解读 · 08-07
异动解读 | Niagen Bioscience盘前大涨20.53%,季度业绩大幅超预期
异动解读 | Niagen Bioscience季报超预期,夜盘股价大涨12.02%
异动解读 · 08-07
异动解读 | Niagen Bioscience季报超预期,夜盘股价大涨12.02%
Roth Capital:维持Niagen Bioscience(NAGE.US)评级,由买入调整至买入评级, 目标价由10.00美元调整至23.00美元。
金融界 · 06-07
Roth Capital:维持Niagen Bioscience(NAGE.US)评级,由买入调整至买入评级, 目标价由10.00美元调整至23.00美元。
暂无数据
公司概况
公司名称:
Niagen Bioscience
所属市场:
NASDAQ
上市日期:
--
主营业务:
Niagen Bioscience, Inc.在特拉华州注册成立。Niagen是一家致力于健康老龄化的全球性生物科学公司。包括世界知名科学家在内的该公司团队正在开创性地研究烟酰胺腺嘌呤二核苷酸(NAD +),这是一种必需的辅酶,是细胞代谢的关键调节因子,存在于人体的每个细胞中。
发行价格:
--
{"stockData":{"symbol":"NAGE","market":"US","secType":"STK","nameCN":"Niagen Bioscience","latestPrice":6.315,"timestamp":1765906084023,"preClose":6.37,"halted":0,"volume":254579,"delay":0,"floatShares":51414700,"shares":79919957,"eps":0.234893,"marketStatus":"交易中","change":-0.055,"latestTime":"12-16 12:28:10 EST","open":6.34,"high":6.43,"low":6.235,"amount":1608209.402007,"amplitude":0.030612,"askPrice":6.32,"askSize":608,"bidPrice":6.31,"bidSize":461,"shortable":3,"etf":0,"ttmEps":0.234893,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765918800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":6.37,"preHourTrading":{"tag":"盘前","latestPrice":6.48,"preClose":6.37,"latestTime":"09:28 EST","volume":2,"amount":12.84,"timestamp":1765895327686},"postHourTrading":{"tag":"盘后","latestPrice":6.3306,"preClose":6.37,"latestTime":"19:12 EST","volume":14393,"amount":91754.335,"timestamp":1765843961750},"volumeRatio":0.719212,"impliedVol":0.872,"impliedVolPercentile":0.582},"requestUrl":"/m/hq/s/NAGE/tweets","defaultTab":"tweets","newsList":[{"id":"1181839553","title":"Niagen Bioscience宣布1000万美元股票回购计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1181839553","media":"投资观察","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181839553?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:59","pubTimestamp":1763571540,"startTime":"0","endTime":"0","summary":"11月6日 - Niagen Bioscience Inc宣布其将实施1000万美元的股票回购计划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","NAGE"],"gpt_icon":0},{"id":"1115306093","title":"Niagen Bioscience Inc:全年重申其最近修订的净销售额增长指引为同比增长25%至30%","url":"https://stock-news.laohu8.com/highlight/detail?id=1115306093","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115306093?lang=zh_cn&edition=full","pubTime":"2025-11-05 05:43","pubTimestamp":1762292589,"startTime":"0","endTime":"0","summary":"Niagen Bioscience Inc:全年重申其最近修订的净销售额增长指引为同比增长25%至30%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","NAGE"],"gpt_icon":0},{"id":"1191323296","title":"异动解读 | Niagen Bioscience盘前大涨20.53%,季度业绩大幅超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1191323296","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191323296?lang=zh_cn&edition=full","pubTime":"2025-08-07 16:17","pubTimestamp":1754554621,"startTime":"0","endTime":"0","summary":"生物科技公司Niagen Bioscience今日盘前股价大涨20.53%,投资者对公司最新发布的季度业绩报告反应热烈。根据公司最新公布的财报,截至6月30日的季度,Niagen Bioscience实现调整后每股收益4美分,大幅超过分析师平均预期的1美分。华尔街对Niagen Bioscience未来12个月的目标价中位数为16.00美元,较上一次收盘价9.16美元高出约42.8%。随着市场对公司业绩和未来增长潜力的信心增强,Niagen Bioscience的股价有望继续保持强劲势头。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NAGE"],"gpt_icon":1},{"id":"1151266894","title":"异动解读 | Niagen Bioscience季报超预期,夜盘股价大涨12.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=1151266894","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151266894?lang=zh_cn&edition=full","pubTime":"2025-08-07 08:12","pubTimestamp":1754525579,"startTime":"0","endTime":"0","summary":"生物科技公司Niagen Bioscience周三夜盘股价大涨12.02%,投资者对公司最新发布的季度业绩报告反应积极。根据公司公布的财报,截至6月30日的季度,Niagen Bioscience实现调整后每股收益4美分,大幅超过分析师平均预期的1美分。值得注意的是,尽管公司股价在本季度下跌了36.4%,但年初至今仍上涨了72.7%。华尔街对Niagen Bioscience未来12个月的目标价中位数为16.00美元,较上一次收盘价9.16美元高出约42.8%。这些因素综合推动了投资者的乐观情绪,促使股价在夜盘交易中大幅上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NAGE"],"gpt_icon":1},{"id":"2541867304","title":"Roth Capital:维持Niagen Bioscience(NAGE.US)评级,由买入调整至买入评级, 目标价由10.00美元调整至23.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2541867304","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541867304?lang=zh_cn&edition=full","pubTime":"2025-06-07 02:05","pubTimestamp":1749233129,"startTime":"0","endTime":"0","summary":"Roth Capital:维持Niagen Bioscience(NAGE.US)评级,由买入调整至买入评级, 目标价由10.00美元调整至23.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/07020550919621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NAGE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.niagenplus.com","stockEarnings":[{"period":"1week","weight":-0.0185},{"period":"1month","weight":-0.0728},{"period":"3month","weight":-0.3288},{"period":"6month","weight":-0.5377},{"period":"1year","weight":0.0408},{"period":"ytd","weight":0.2008}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.1266},{"period":"ytd","weight":0.1615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Niagen Bioscience, Inc.在特拉华州注册成立。Niagen是一家致力于健康老龄化的全球性生物科学公司。包括世界知名科学家在内的该公司团队正在开创性地研究烟酰胺腺嘌呤二核苷酸(NAD +),这是一种必需的辅酶,是细胞代谢的关键调节因子,存在于人体的每个细胞中。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":-0.043813},{"month":2,"riseRate":0.555556,"avgChangeRate":0.218645},{"month":3,"riseRate":0.333333,"avgChangeRate":0.069369},{"month":4,"riseRate":0.555556,"avgChangeRate":0.036039},{"month":5,"riseRate":0.5,"avgChangeRate":0.021036},{"month":6,"riseRate":0.6,"avgChangeRate":0.068253},{"month":7,"riseRate":0.5,"avgChangeRate":-0.007412},{"month":8,"riseRate":0.3,"avgChangeRate":-0.041379},{"month":9,"riseRate":0.3,"avgChangeRate":-0.054309},{"month":10,"riseRate":0.2,"avgChangeRate":-0.056092},{"month":11,"riseRate":0.7,"avgChangeRate":0.200397},{"month":12,"riseRate":0.3,"avgChangeRate":-0.023909}],"exchange":"NASDAQ","name":"Niagen Bioscience","nameEN":"Niagen Bioscience"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Niagen Bioscience(NAGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Niagen Bioscience(NAGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Niagen Bioscience,NAGE,Niagen Bioscience股票,Niagen Bioscience股票老虎,Niagen Bioscience股票老虎国际,Niagen Bioscience行情,Niagen Bioscience股票行情,Niagen Bioscience股价,Niagen Bioscience股市,Niagen Bioscience股票价格,Niagen Bioscience股票交易,Niagen Bioscience股票购买,Niagen Bioscience股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Niagen Bioscience(NAGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Niagen Bioscience(NAGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}